Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.
Hideaki Tsuji; Ran Nakashima; Yuji Hosono; Yoshitaka Imura; Masato Yagita; Hajime Yoshifuji; Shintaro Hirata; Takaki Nojima; Eiji Sugiyama; Kazuhiro Hatta; Yoshio Taguchi; Masaki Katayama; Kiminobu Tanizawa; Tomohiro Handa; Ryuji Uozumi; Shuji Akizuki; Kosaku Murakami; Motomu Hashimoto; Masao Tanaka; Koichiro Ohmura; Tsuneyo Mimori
Arthritis & rheumatology (Hoboken, N.J.), Mar. 2020, Peer-reviewed